Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry

BACKGROUND: Oral anticoagulation (OAC) in atrial fibrillation (AF) reduces the risk of stroke/systemic embolism (SE). The impact of OAC discontinuation is less well documented. OBJECTIVE: Investigate outcomes of patients prospectively enrolled in the Global Anticoagulant Registry in the Field‐Atrial...

Descrizione completa

Dettagli Bibliografici
Autori principali: Cools, Frank, Johnson, Dana, Camm, Alan J., Bassand, Jean‐Pierre, Verheugt, Freek W. A., Yang, Shu, Tsiatis, Anastasios, Fitzmaurice, David A., Goldhaber, Samuel Z., Kayani, Gloria, Goto, Shinya, Haas, Sylvia, Misselwitz, Frank, Turpie, Alexander G. G., Fox, Keith A. A., Pieper, Karen S., Kakkar, Ajay K.
Natura: Online Articolo testo
Lingua:English
Pubblicazione: John Wiley and Sons Inc. 2021
Soggetti:
VASCULAR BIOLOGY
Accesso online:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390436/
https://www.ncbi.nlm.nih.gov/pubmed/34060704
http://dx.doi.org/10.1111/jth.15415

Accesso online

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390436/
https://www.ncbi.nlm.nih.gov/pubmed/34060704
http://dx.doi.org/10.1111/jth.15415

Documenti analoghi